| OVERALL PORTFOLIO COMPOSITION (%) | |
| Cash: | 0.01 | | Stocks: | 99.74 | | Bonds: | N/A | | Other: | 0.25 |
|
| TOP 10 HOLDINGS ( 66.32% OF TOTAL ASSETS) | |
| Company | Symbol | % Assets | YTD Return % | | Amgen Inc. | AMGN | 21.24 | -1.16 | | Biogen Idec Inc | BIIB | 8.68 | 0.44 | | Alexion Pharmaceuticals, Inc. | ALXN | 6.38 | 27.38 | | Vertex Pharmaceuticals Incorpor | VRTX | 5.01 | 31.20 | | United Therapeutics Corporation | UTHR | 4.89 | 46.54 | | Gilead Sciences, Inc. | GILD | 4.57 | -9.27 | | Genzyme Corporation | GENZ | 4.57 | -22.99 | | Cephalon, Inc. | CEPH | 3.71 | -28.19 | | Acorda Therapeutics, Inc. | ACOR | 3.66 | 19.94 | | Celgene Corporation | CELG | 3.61 | 1.85 |
|
| Averages | FBTBX | Category Avg | | Price/Earnings | 16.84 | 17.67 | | Price/Book | 3.31 | 2.79 | | Price/Sales | 4.83 | 1.45 | | Price/Cashflow | 13.58 | 12.03 | | Median Market Cap | 5.62B | 14.68B | | 3 Year Earnings Growth | N/A | 16.07% |
|
| Sector | | FBTBX | Category Avg | | Utilities | | 0.00 | 0.04 | | Business services | | 0.00 | 0.24 | | Financials | | 0.00 | 0.17 | | Telecommunications | | 0.00 | 1.78 | | Media | | 0.00 | 0.01 | | Consumer goods | | 0.00 | 0.36 | | Energy | | 0.00 | 0.00 | | Hardware | | 0.00 | 0.40 | | Health | | 100.00 | 90.32 | | Software | | 0.00 | 1.04 | | Consumer services | | 0.00 | 5.39 | | Industrial materials | | 0.00 | 0.25 |
|
| Sector | FBTBX | Category Avg | | US GOVERNMENT | N/A | N/A | | AAA | N/A | N/A | | AA | N/A | N/A | | A | N/A | N/A | | BBB | N/A | N/A | | BB | N/A | N/A | | B | N/A | N/A | | BELOW B | N/A | N/A | | OTHER | N/A | N/A |
|
| Averages | FBTBX | Category Avg | |
Maturity
| N/A | N/A | |
Duration
| N/A | N/A | |
Credit Quality
| N/A | N/A |
|
| |
|
0.11% Nasdaq 
0.01%
Holdings
